The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis
Open accessAbstract
Background—Infection of pancreatic necrosis has a major impact on clinical course, management, and outcome in acute pancreatitis. Currently, guided fine needle aspiration is the only means for an early and accurate diagnosis of infected necrosis. Procalcitonin (PCT), a 116 amino acid propeptide of calcitonin, and interleukin 8 (IL-8), a strong neutrophil activating cytokine, are markers of severe inflammation and sepsis. Aims—To analyse the clinical value of PCT and IL-8 as biochemical parameters for predicting infected necrosis in acute pancreatitis. Patients and methods—Fifty patients with acute pancreatitis entered this prospective study and were stratified into three groups according to morphological and bacteriological findings: 18 patients with oedematous pancreatitis (group I), 14 patients with sterile necrosis (group II), and 18 patients who developed infected necrosis a median of 13.5 days after the onset of symptoms (group III). After admission serum samples were drawn daily for two weeks. Concentrations of PCT and IL-8 were measured by chemoluminescent immunoassays (upper reference range 0.5 ng/ml for PCT and 70 pg/ml for IL-8). The routine parameter C-reactive protein was determined by laser nephelometry (upper reference range 10 mg/l). Results—Median concentrations of PCT and IL-8 were significantly higher in patients with infected necrosis than in those with sterile necrosis during the observation period, whereas there was no difference in C-reactive protein. In oedematous pancreatitis overall median concentrations of all three parameters were low. By receiver operating characteristics best cut off levels for predicting infected necrosis or persisting pancreatic sepsis were 1.8 ng/ml for PCT and 112 pg/ml for IL-8. If these cut off levels were reached on at least two days, sensitivity, specificity, and accuracy for the prediction of infected necrosis were 94%, 91%, and 92% for PCT and 72%, 75%, and 74% for IL-8, respectively. After surgical treatment of infected necrosis median PCT and IL-8 values continued to be significantly higher in patients with persisting pancreatic sepsis (n=11) compared with those having an uneventful postoperative course (n=7). For the preoperative differentiation between infected necrosis and sterile necrosis guided fine needle aspiration was performed in 24 patients with necrotising pancreatitis and reached a diagnostic accuracy of 84% compared with 87% for PCT, and 68% for IL-8. There was no correlation between the aetiology of acute pancreatitis or the extent of necrosis and PCT or IL-8. Conclusion—PCT and IL-8 are found in high concentrations in infected necrosis and associated systemic complications in patients with acute pancreatitis. The course of PCT shows the closest correlation with the presence of infected necrosis. Monitoring of serum PCT is a potential new marker for the non-invasive and accurate prediction of infected necrosis as well as for the selection of patients with persisting septic complications after surgical debridement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High serum procalcitonin concentrations in patients with sepsis and infection
Assicot, M., Bohuon, C., Gendrel, D., Raymond, J., Carsin, H., & Guilbaud, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)90277-n · Cited by 2,197
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.
Baggiolini, M., Walz, A., & Kunkel, S. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114265 · Cited by 1,975
Multiple-Organ Failure: Generalized Autodestructive Inflammation?
Goris, R. J. A. (1985) · Archives of Surgery · doi:10.1001/archsurg.1985.01390340007001 · Cited by 1,289
Procalcitonin increase after endotoxin injection in normal subjects
Dandona, P. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.6.1605 · Cited by 965
Bacterial contamination of pancreatic necrosis
Beger, H. G., Bittner, R., Block, S., & Büchler, M. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90579-2 · Cited by 924
Self-citation(1999) · Burn Care · doi:10.1201/9781498713979-15 · Cited by 819
Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups
Donnelly, S. C., Haslett, C., Strieter, R. M., Kunkel, S. L., Walz, A., Robertson, C. R., Carter, D. C., Pollok, A. J., & Grant, I. S. (1993) · The Lancet · doi:10.1016/0140-6736(93)90416-e · Cited by 676
The use of relative operating characteristic (ROC) curves in test performance evaluation.
Beck, & Shultz, E. K. (1986) · PubMed · Cited by 621
MedCalc: a new computer program for medical statistics
Schoonjans, F., Zalata, A., Depuydt, C. E., & Comhaire, F. H. (1995) · Computer Methods and Programs in Biomedicine · doi:10.1016/0169-2607(95)01703-8 · Cited by 547
Wilson, C., Heath, D. I., & Imrie, C. W. (1990) · Journal of British Surgery · doi:10.1002/bjs.1800771120 · Cited by 474
Cited by
Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome
Bhatia, M., & Moochhala, S. (2004) · The Journal of Pathology · doi:10.1002/path.1491 · Cited by 1,095
HARBARTH, S., HOLECKOVA, K., FROIDEVAUX, C., PITTET, D., RICOU, B., GRAU, G. E., VADAS, L., PUGIN, J., & the Geneva Sepsis Network (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.3.2009052 · Cited by 898
Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications
Mayer, J., Rau, B., Gansauge, F., & Beger, H. G. (2000) · Gut · doi:10.1136/gut.47.4.546 · Cited by 666
Self-citationCalcitonin precursors are reliable markers of sepsis in a medical intensive care unit
Müller, B., Becker, K. L., Schächinger, H., Rickenbacher, P. R., Huber, P. R., Zimmerli, W., & Ritz, R. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004000-00011 · Cited by 628
Neoptolemos, J., Kemppainen, E., Mayer, J., Fitzpatrick, J., Raraty, M., Slavin, J., Beger, H.-G., Hietaranta, A., & Puolakkainen, P. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02327-8 · Cited by 623
Self-citationBecker, K. L., Nylén, E. S., White, J. C., Müller, B., & Snider, R. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021444 · Cited by 578
Pathophysiology of acute pancreatitis
Bhatia, M., Wong, F. L., Cao, Y., Lau, H. Y., Huang, J., Puneet, P., & Chevali, L. (2005) · Pancreatology · doi:10.1159/000085265 · Cited by 544
Inflammatory mediators in acute pancreatitis
Bhatia, M., Brady, M., Shokuhi, S., Christmas, S., Neoptolemos, J. P., & Slavin, J. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200002)190:2<117::aid-path494>3.0.co;2-k · Cited by 534
New Approaches to Sepsis: Molecular Diagnostics and Biomarkers
Reinhart, K., Bauer, M., Riedemann, N. C., & Hartog, C. S. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-12 · Cited by 533
Dervenis, C., Johnson, C. D., Bassi, C., Bradley, E., Imrie, C. W., McMahon, M. J., & Modlin, I. (1999) · International journal of pancreatology · doi:10.1007/bf02925968 · Cited by 451
Comparison of procalcitonin and C-reactive protein as markers of sepsis
Luzzani, A., Polati, E., Dorizzi, R., Rungatscher, A., Pavan, R., & Merlini, A. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000063440.19188.ed · Cited by 425
Carter, C. R., McKay, C. J., & Imrie, C. W. (2000) · Annals of Surgery · doi:10.1097/00000658-200008000-00004 · Cited by 418
Castelli, G. P., Pognani, C., Meisner, M., Stuani, A., Bellomi, D., & Sgarbi, L. (2004) · Critical Care · doi:10.1186/cc2877 · Cited by 417
A critical evaluation of laboratory tests in acute pancreatitis
Yadav, D. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04122-9 · Cited by 375
Procalcitonin in bacterial infections - hype, hope, more or less?
Christ-Carin, M. (2005) · Swiss Medical Weekly · doi:10.4414/smw.2005.11169 · Cited by 367
Management of the critically ill patient with severe acute pancreatitis
Nathens, A. B., Curtis, J. R., Beale, R. J., Cook, D. J., Moreno, R. P., Romand, J.-A., Skerrett, S. J., Stapleton, R. D., Ware, L. B., & Waldmann, C. S. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000148222.09869.92 · Cited by 357
Pathobiochemistry and clinical use of procalcitonin
Meisner, M. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00101-8 · Cited by 333
Isenmann, R., Rau, B., & Beger, H. G. (1999) · Journal of British Surgery · doi:10.1046/j.1365-2168.1999.01176.x · Cited by 331
Self-citationSevere acute pancreatitis: Clinical course and management
Beger, H. G. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i38.5043 · Cited by 307
Self-citationProcalcitonin behaves as a fast responding acute phase protein in vivo and in vitro
Nijsten, M. W. N., Olinga, P., The, H. T., de Vries, E. G. E., Koops, H. S., Groothuis, G. M. M., Limburg, P. C., ten Duis, H. J., Moshage, H., Hoekstra, H. J., et al. (2000) · Critical Care Medicine · doi:10.1097/00003246-200002000-00028 · Cited by 295
Factors Predicting Mortality in Severe Acute Pancreatitis
Compañy, L., Sáez, J., Martínez, J., Aparicio, J. R., Laveda, R., Griño, P., & Pérez-Mateo, M. (2003) · Pancreatology · doi:10.1159/000070083 · Cited by 282
Pathogenic mechanisms of pancreatitis
Manohar, M., Verma, A. K., Venkateshaiah, S. U., Sanders, N. L., & Mishra, A. (2017) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v8.i1.10 · Cited by 269
Wanner, G. A., Keel, M., Steckholzer, U., Beier, W., Stocker, R., & Ertel, W. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004000-00007 · Cited by 263
Forty years of calcitonin—where are we now? A tribute to the work of Iain Macintyre, FRS
Zaidi, M., Inzerillo, A. M., Moonga, B. S., Bevis, P. J. R., & Huang, C. L.-H. (2002) · Bone · doi:10.1016/s8756-3282(02)00688-9 · Cited by 151
Metadata
- Authors
- Rau, B., Steinbach, G., Gansauge, F., Mayer, J. M., Grünert, A., & Beger, H. G.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 1997-12-01
- Volume
- 41
- Issue
- 6
- Pages
- 832-840
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2100504222
- Cited by
- 375
- References
- 24
- FWCI
- 25.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.